** Shares of Assertio Holdings Inc ASRT.O rise 8.7% to
$4.3 before the bell
** Drugmaker raises its FY 2022 revenue forecast to a range
of $129 mln to $137 mln from $126 mln to $136 mln urn:newsml:reuters.com:*:nGNX7L7JXK
** Reports Q2 adjusted net profit of 28 cents per share,
surging past estimates of 8 cents per share - Refinitiv IBES
Data
** Co's Q2 sales increased 40% to $35.4 mln on higher demand
for its bacterial infection drug, Indocin
** Up to Friday's close, stock up 83% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))